Abstract

Limprint has been a truly International study with 9 countries and 41 sites within those countries taking active roles. We must acknowledge the commitment and work of all the Investigators and thank the many patients who agreed to be a part of it. Additional thanks to all the Frameworks for their help in the development of the method for this study which ensured that we had consensus over all aspects.
Our thanks must, of course, go to 3M for giving the International Lymphoedema Framework an unrestricted educational grant, an electronic platform and all the support they provided. We must mention here Monica Wheeler from 3M for her amazing input to the study.
Finally, our thanks to ILF Directors who gave unwavering support throughout this project.
The countries involved and their Academic Leads are:
Australia Professor Sue Gordon Canada Dr. David Keast Denmark Susan Noerregaard France Professor Isabelle Quere Ireland Professor Mary-Paula Colgan Italy Professor Sandro Michelini Japan Professor Hiromi Sanada Turkey Professor Pinar Borman United Kingdom Professor Christine Moffatt
